期刊文献+

新型磷酸二酯酶4抑制剂ZL-n-91对人神经胶质瘤细胞增殖、周期及凋亡的影响 被引量:1

Effect of a novel phosphodiesterase 4 inhibitor ZL-n-91 on proliferation,cell cycle and apoptosis of human glioma U87 cells
下载PDF
导出
摘要 目的探讨新型磷酸二酯酶4抑制剂ZL-n-91对人神经胶质瘤U87细胞增殖、周期及凋亡的影响。方法体外实验,CCK-8法检测不同浓度的ZL-n-91作用U87细胞48 h后细胞增殖抑制情况;流式细胞术检测U87细胞周期和凋亡变化;Western blot检测细胞周期蛋白CDK2、CDK4、Cyclin D1及凋亡蛋白Bax和Bcl-2的表达;体内实验,构建U87皮下移植瘤模型,检测5 mg·kg^(-1) ZL-n-91对神经胶质瘤的治疗作用。结果ZL-n-91呈浓度依赖性抑制U87细胞增殖(P<0.01),IC50值为274.5μmol·L^(-1);与对照组相比,经ZL-n-91处理后U87细胞出现明显的G0/G1期阻滞(P<0.01),并呈现剂量依赖性诱导细胞凋亡(P<0.05);Western blot结果表明,ZL-n-91降低了胶质瘤细胞CDK2、CDK4、Cyclin D1、Bcl-2蛋白的表达(P<0.05);体内实验表明,ZL-n-91显著抑制U87皮下移植瘤的生长(P<0.05)。结论新型PDE4抑制剂ZL-n-91显著抑制神经胶质瘤U87细胞的增殖,将细胞阻滞在G0/G1期,可能通过Bcl-2/Bax途径诱导细胞凋亡。 Aim To investigate the effect of ZL-n-91,a novel phosphodiesterase 4(PDE4)inhibitor,on proliferation,cell cycle and apoptosis of human glioma U87 cells.Methods In vitro the different concentrations of ZL-n-91 were set up to evaluate the proliferation of U87 cells by CCK-8 assay.The cell apoptosis and cell cycle distribution were examined by flow cytometry.The expression of CDK2,CDK4,cyclin D1 and apoptosis-related protein Bax and Bcl-2 proteins were detected by Western blot.A subcutaneous transplanted tumor model of U87 in nude mice was established for the in vivo experiment using a dosage of 5mg·kg^(-1) of ZL-n-91.Results ZL-n-91 significantly inhibited the proliferation of U87 cells with concentration dependence,and the IC50 value was 274.5μmol·L^(-1).In addition,ZL-n-91 induced G0/G1 cell cycle arrest in U87 cancer cells(P<0.0l).Meanwhile,ZL-n-91 treatment induced apoptosis in a dose-dependent manner.Western blot analysis demonstrated that ZL-n-91 down-regulated the expression of CDK2,CDK4,cyclin D1 and Bcl-2(P<0.05).Furthermore,ZL-n-91 significantly inhibited the growth of transplanted U87-derived tumor in the nude mice.Conclusions ZL-n-91,a novel PDE4 inhibitor,can significantly inhibit the proliferation of U87 cells,promote cell arrest in G0/G1 phase,and probably induce cell apoptosis through the Bcl-2/Bax pathway.
作者 李玉玉 毛萍 赵正刚 李美蓉 赵夏楠 李芳红 周素瑾 赵子建 LI Yu-yu;MAO Ping;ZHAO Zheng-gang;LI Mei-rong;ZHAO Xia-nan;LI Fang-hong;ZHOU Su-jin;ZHAO Zi-jian(School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2021年第7期952-957,共6页 Chinese Pharmacological Bulletin
基金 广东省“珠江人才计划”项目(No 2016ZT06Y432) 国家重点研发计划(No 2018YFA0800603) 广东省重点领域研发计划新药创制项目(No 2019B020201015)。
关键词 ZL-n-91 神经胶质瘤 PDE4抑制剂 磷酸二酯酶4 增殖 周期 凋亡 ZL-n-91 glioma PDE4 inhibitor phosphodiesterase 4 proliferation cell cycle apoptosis
  • 相关文献

参考文献5

二级参考文献35

  • 1杨振淮,郭洁文,潘竞锵,李关宁.蛇葡萄属植物抗肿瘤、抗氧化、护肝和调血脂的药理作用研究[J].中医研究,2004,17(4):57-58. 被引量:11
  • 2Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015, 65(1): 5-29.
  • 3Francis SH, Blount MA, Corbin JD, et al. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions[J]. Physiol Rev, 2011, 91(2): 651-690.
  • 4Eskandari N, Mirmosayyeb O, Bordbafi G, et al. A short review on structure and role of cyclic-3',5'-adenosine monophospbate-specific phosphodiesterase 4 as a treatment tool[J]. J Res Pharm Pract, 2015, 4 (4): 175-181.
  • 5Ma R, Yang BY, Wu CY. A selective phosphodiesterase 4 (PDE4) inhibitor ZI-n-91 suppresses IL-17 production by human memory Thl7 cells[J]. Int lmmunopharmacol, 2008, 8(10): 1408-1417.
  • 6Parikh N, Chakraborti AK. Phosphodiesterase 4 (PDE4) lnhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions[J]. Curr Med Chem, 2016, 23(2): 129-141.
  • 7Wang YJ, Jiang YL, Tang HF, et al. Zl-n-91, a selective phospbodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model[J], lnt Immunopharmacol, 2010, 10(2): 252-258.
  • 8Page CP. Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease[J]. Int Arch Allergy Immunol, 2014, 165(3): 152-164.
  • 9Schett G. Apremilast in psoriatic arthritis [J]. Clin Exp Rbeumatol, 2015, 33(5 Suppl 93): S98-100.
  • 10Gooderham M, Papp K. Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast[J]. BioDrugs, 2015, 29(5): 327-339.

共引文献307

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部